505
Participants
Start Date
May 31, 2007
Primary Completion Date
June 30, 2009
Study Completion Date
June 30, 2009
Naltrexone SR 32 mg/bupropion SR 360 mg/ day
Placebo
Ancillary therapy
Ancillary therapy consisting of diet instruction, advice on behavior modification, and exercise counseling
Diabetes care and Information Center, Flushing
Central New York Clinical Research, Manlius
Rochester Clinical Research, Inc, Rochester
Health Trends Research, LLC, Baltimore
Metrolina Medical Research, Charlotte
Mountain View Clinical Research, Greer
Palmetto Medical Research, Mt. Pleasant
CSRA Partners in Health, Inc, Augusta
University Clinical Research, Pembroke Pines
Miami Research Associates, Miami
LCFP Inc., Fort Myers
Suncoast Clinical Research, Palm Harbor
SelfCenter, PC, Fairhope
Clinical Research Associates, Inc., Nashville
ClinSearch, Chattanooga
L-Marc, Louisville
Central Kentucky Research Associates, Inc., Lexington
Trover Center for Clinical Studies, Madisonville
Central Ohio Nutrition Center, Inc., Columbus
Your Diabetes Endocrine and Nutrition Group, Mentor
Rapid Medical Research, Inc., Cleveland
Wells Institute for Health Awareness, Kettering
Northwest Indiana Center for Clinical Research, Valparaiso
Deaconess Clinic, Evansville
Twin Cities Clinical Research, Brooklyn Center
Mercy Health Research, St Louis
Radiant Research, Inc., St Louis
The Center for Pharmaceutical Research, Kansas City
Medical Research Institute, Slidell
Pennington Biomedical Research Center, Baton Rouge
HealthStar Research, Hot Springs
The Cooper Institute, Dallas
Baylor Endocrine Center, Dallas
InVisions Consultants, LLC, San Antonio
Diabetes Center of the Southwest, Midland
HOPE Research Institute, Phoenix
Pivotal Research Centers, Peoria
Lovelace Scientific Resources, Albuquerque
Center for Nutrition and Metabolic Diseases, Univ. of Nevada, Reno
Impact Clinical Trials, Beverly Hills
Affiliated Research Institute, San Diego
VA San Diego Healthcare System, San Diego
Apex Research Institue, Santa Ana
Advance Clinical Research Institute, Orange
Sierra Medical Research, Fresno
East-West Medical Research Institute, Honolulu
Summit Research Network, Inc., Seattle
Northern California Research, Carmichael
Northside Internal Medicine, Spokane
Chase Medical Research, LLC, Waterbury
FutureCare Studies, Springfield
Endocrinology & Diabetes Consultants, Dover
Diabetes & Glandular Disease Research Associates, Inc., San Antonio
Lead Sponsor
Orexigen Therapeutics, Inc
INDUSTRY